{"nct_id":"NCT05514444","title":"Study of MK-4464 as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced/Metastatic Solid Tumors (MK-4464-001)","status":"COMPLETED","status_verified_date":"2025-10","start_date":"2022-09-25","start_date_type":"ACTUAL","primary_completion_date":"2025-09-18","primary_completion_date_type":"ACTUAL","completion_date":"2025-09-18","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["MRK"]}